key: cord-0792789-vopuw2zd
authors: Benarroch, Yoel; Juttukonda, Lillian; Sabharwal, Vishakha; Boateng, Jeffery; Khan, Amir R.; Yarrington, Christina; Wachman, Elisha M.; Taglauer, Elizabeth
title: Differential expression of Rab5 and Rab7 small GTPase proteins in placental tissues from pregnancies affected by maternal COVID-19
date: 2021-01-08
journal: Clin Ther
DOI: 10.1016/j.clinthera.2021.01.002
sha: 06f3afc965cdd73a878775f9a154eb53f54cb11c
doc_id: 792789
cord_uid: vopuw2zd

Purpose The majority of pregnancies affected by maternal COVID-19 do not result in fetal transmission, yet several studies have identified parenchymal changes in their placental tissues, suggesting a placental response to SARS-CoV-2 at the maternal-fetal interface. While many COVID-19 placental studies have focused on the expression of canonical SARS-CoV-2 entry proteins angiotensin-converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2), further characterization of subcellular molecules involved in viral trafficking have not yet been investigated in these tissues. Of interest are Rab proteins, a family of small GTPase proteins that direct intracellular transport between different endocytic organelles. Rab5 and Rab7 in particular have previously been implicated in human immunodeficiency virus (HIV) and cytomegalovirus (CMV) invasion of placental trophoblast cells in vitro, but the localization of these molecules has not been fully characterized within the human maternal-fetal interface or within placental tissues from SARS-CoV-2 infected pregnancies. Methods Using fluorescent immunohistochemistry, Rab5 and Rab7 placental localization and comparative fluorescence intensity was explored in a cohort of placental tissues from pregnancies affected by maternal COVID-19 disease (“COVID”, n=15) in comparison with contemporary controls (“Control”, n=10). Fluorescence intensity was quantified using corrected total cell fluorescence (CTCF) values. Findings Within placental villi, Rab5 was consistently localized in syncytiotrophoblast cells (sTB) and cytotrophoblast cells (cTB). Rab5 had significantly higher fluorescence intensity in the COVID cohort (Control mean 1.96 +/- SEM 0.16 vs COVID mean 2.62 +/- SEM 0.09, p=0.0014). In contrast, while Rab7 was also localized within placental villous sTB and cTB, Rab7 fluorescence intensity was significantly downregulated in COVID vs Control placentas (Control mean 35.9 +/- SEM 4.1 vs mean 20.1 +/- SEM 0.52, p= 0.0001). Implications This differential expression of Rab5 and Rab7 suggests that placental endocytic pathways may be altered at the maternal-fetal interface in pregnancies affected by maternal SARS-CoV-2 infection. As key molecules governing intracellular vesicle transport including viral trafficking, RabGTPase proteins may of interest for ongoing studies examining placental responses to COVID-19 in pregnancy.

With over ten million confirmed cases and several hundred thousand deaths reported worldwide, 29 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the novel infectious agent responsible 30

for Coronavirus disease 2019 (COVID-19) remains a significant global health burden. 1 Of particular 31 interest is the study of COVID-19 in pregnancy. With prolonged maternal-fetal exposures being a 32 physiologic necessity for healthy gestation, viral transmission of SARS-CoV-2 in pregnancy cannot be 33 combatted through normal quarantine measures. However, low rates of fetal transmission (1-4%) have 34 been consistently reported throughout the pandemic. 2, 3 As the main exchange interface between mother 35 and fetus in pregnancy, the placenta appears to be creating a physiologic barrier against fetal infection of 36 SARS-CoV-2. However, the mechanisms governing the lack of fetal transmission remain unclear. Here 37

we will review the current literature on COVID-19 in pregnancy and placental responses to SARS-CoV-2 38

infection. Additionally, we will present novel data from a pilot study examining the expression of 39 selected proteins involved in endocytic vesicle trafficking in a cohort of placental tissues from 40 pregnancies affected by maternal COVID-19, highlighting a potential new direction for the study of 41 SARS-CoV-2 responses at the maternal-fetal interface. 42

While pregnant women have been estimated to make up only 9% of SARS-CoV-2 positive cases 43 among women of reproductive age in the United States 4 , they appear to be particularly susceptible to 44 complications of COVID-19 disease, with reports of increased disease severity and higher rates of 45 hospitalization as compared to other adult populations. 5, 6 Regarding perinatal clinical signs in newborns 46 of mothers with positive SARS-CoV-2 tests, studies have reported mixed results. Interestingly, infants 47 thrombocytopenia, vomiting, fever, tachycardia, and low birth weight have been reported. 11-13 However, 53 the majority of the literature has reported normal findings (e.g. APGAR scores, birth weight) in neonates 54 born to SARS-CoV-2 positive mothers. 7, 12, 14-18 55

Despite a significant increase in research on COVID-19 disease in pregnancy in 2020, questions 56 remain about the risk for transmission of SARS-CoV-2 from mother to fetus (i.e. vertical transmission). 57

Prior to the current pandemic, coronavirus has not been associated with vertical transmission. This was 58 true for both SARS-CoV-1 and Middle East respiratory syndrome-Coronavirus (MERS-CoV), which 59

were responsible for major outbreaks in 2002 and 2012. 19, 20 Selected studies to date have suggested 60 vertical transmission of SARS-CoV-2 based on positive IgM antibody lab tests in three neonates, 61 however the sensitivity and specificity of these serological tests have been questioned. 12, 21, 22 Other case 62 series and reports have further identified positive results for SARS-CoV-2 from infants' pharyngeal 63 swabs by 8, 10, 23 In one patient, placental biopsies from a stillbirth tested positive immediately 64 after expulsion and at 24 hours. 24 Another study reported SARS-CoV-2 positive samples from placental 65 or membrane swabs in three pregnant patients, but neonatal swabs were all negative. 25 Patane et al. 66

reported positive RT-PCR tests for two of 22 mother-neonate dyads, as well as both of their placentas. 23 67

Nevertheless, the majority of COVID-19 studies in neonatal settings have found no evidence of viral 68 RNA in pharyngeal swabs, blood, feces, or urine. 7, 8, 10-13, 16-18, 25, 26 Furthermore, breast milk and vaginal 69 secretions have yielded negative SARS-CoV-2 results. 16, 27 70

The COVID-19 pregnancy literature to date has largely focused on various clinical 78 manifestations, epidemiology and placental pathology while few studies have fully evaluated mechanisms 79 governing the low rates of fetal transmission and/or the placental cellular responses to maternal SARS-80

CoV-2 infection. The symbiotic maternal-fetal physiology required for pregnancy maintenance and 81 normal fetal development necessitates close and prolonged exposures between mother and fetus 82 throughout gestation. However, despite these exposures, vertical transmission between mother and fetus 83 remains a heterogenous process with a broad variability in maternal infections which result in true fetal 84 pathology. 33 In viral infections where vertical transmission is prevented, the placenta can be a key 85 boundary providing physiologic viral blockade. 86

Placenta villi are the main anatomical interface between mother and infant during pregnancy 87 ( Figure 1A ) and are comprised of placental cell layers covering a central core of fetal blood vessels. 34 88

These placental cells, termed villous trophoblasts are subdivided into syncytiotrophoblasts (sTB) which 89 are fed by an underlying layer of cytotrophoblast cells (cTB) ( Figure 1B ). sTB form a monolayer on the 90 outer aspect of the placental villous which lies in direct contact with maternal blood and juxtaposed with 91 cTB and fetal blood vessels. Trafficking between the sTB layer, cTB and fetal blood vessels thus 92 comprises the main cellular exchange interface between mother and fetus during pregnancy ( Figure 1B) . 93

Thus, it is important to evaluate the more sub-anatomical aspects of placental tissues to evaluate where a 94 potential SARS-CoV-2 blockade could be occurring at the maternal-fetal interface and identify areas for 95 future investigation. 96

In ongoing evaluations of COVID-19 in pregnancy, there has been varied evidence of SARS-97 percentages of fetal transmission (1-4%), 2, 3 suggesting that even if SARS-CoV-2 gains access to the 104 placental compartment, other mechanisms may still be in place preventing its subsequent transmission to 105 the developing fetus. 106 SARS-CoV-2 cellular entry proteins have also been investigated in placental tissues. It has been 107 well established that the SARS-CoV-2 spike protein and the host cell proteins angiotensin-converting 108 enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2) are required for cell entry and Rab5 and Rab7 regulate the biogenesis of early endosomes and endo-lysosomal trafficking respectively, 125 while Rab11 is critical for endocytic recycling to the plasma membrane. 47, 48 Our previous work has 126 demonstrated that Rab11 is prominently expressed within trophoblast cells and fetal blood vessels in 127 normal human placental tissues ( Figure 1C ). 49 Rab 5 and Rab7 have been implicated in HIV and CMV 128 entry into trophoblast cells in vitro, but the localization of these molecules has not been fully Immunohistochemistry: Placental tissue sections were first subjected to antigen retrieval with 10mM 157

Sodium citrate, 0.05% Tween 20, pH 6, boiling for 20 minutes followed by a series of washes with PBS 158 0.05% Tween 20 (PBS-T). Slides were then incubated for 1 hour at room temperature in PBS with 159 permeabilization solution 0.2% Triton X-100 along with 10% blocking serum of host species for all This study highlights Rab GTPases as placental targets of interest for ongoing analysis COVID-216 19 in pregnancy. The differential expression of Rab5 and Rab7 in COVID placental tissues suggests 217 trophoblast-specific molecular alterations in response to SARS-CoV-2 at the maternal-fetal interface. 218

While these results require ongoing validation, they are consistent with prior work examining Rab5 and 219

Rab7 expression in host-cell pathogen interactions. Bacterial components muramyl dipeptide (found in 220 both gram positive and gram negative bacteria) has been shown to have opposing effects on Rab5 and 221

Rab7 expression in macrophages, corresponding with pathogen lysosomal degradation. 55 Further, while 222 mechanisms dictating Rab protein expression are multifactorial, some key themes emerge from their 223 regulation in response to infection. 46 Rab5 and Rab7 appear to be governed by distinct signaling 224 pathways in response to cytokine production 56 . Rab5 can be upregulated in response to proinflammatory 225 cytokines such as IL-6 via activation of extracellular signal-regulated kinase (ERK) pathway. In contrast, 226 Rab7 can be altered by an IL-12 dependent, p38/MAPK directed pathway. As altered levels of both IL-6 227 and IL-12 are among the systemic cytokine responses associated with COVID-19 disease 57 intrauterine 228 cytokine changes could be one of the determinants driving altered expression of Rab5 and Rab7 in these 229 placental tissues. However, as the pregnancy-specific cytokine profiles of maternal COVID-19 infection 230

have not been well-defined, ongoing studies will be needed to identify factors regulating Rab5 and Rab7 231 differential expression in placental tissues and the potential role of these proteins in the SARS-CoV-2 232 response at the maternal-fetal interface. 233

The current study has several limitations. First, it is a pilot analysis of histological findings in a 234 selected cohort of fixed placental tissues. While differences were observed between groups, this initial 235 data requires ongoing validation with comparative evaluation of mRNA and protein expression in greater 236 numbers of freshly preserved samples. Additionally, these tissues were collected from pregnancies 237 during a specific timeframe during a peak of admissions and illness severity in the early stages of the 238 COVID-19 pandemic. Ongoing evaluation of placental tissues from COVID-19 positive pregnancies 239 over a broader timeframe and clinical heterogeneity will be informative to capture a more complete 240 picture of Rab5 and Rab7 expression changes. Finally, Rab protein expression was only evaluated in 241 pregnancies with maternal COVID-19 in the third trimester. Analysis across first, second and third 242 trimester maternal SARS-CoV-2 infections will be informative to evaluate how the placental expression 243 of these proteins changes relative to the gestational timing of maternal Overall, this work highlights the importance of investigating additional sub-cellular pathways to 245 more fully understand the placental response to COVID-19 in pregnancy. As Rab5 regulates early 246 endosome processes and Rab7 directs early to late endosomal transport 58 , future evaluation of endosomal 247 subtype markers will also be a key area of investigation. Comparative analysis of early endosome antigen 248 1 (EEA1) a marker of early endosomes and CD63 a late endosome and multi-vesicular body (MBV) 249 marker could be informative to identify whether downregulation of Rab7 in COVID placental tissues 250 results in retention of the virus in early endosomes or trapping within late endosomes and MVB. It is 251 important to note that within our COVID placental cohort, Rab5 upregulation and Rab7 downregulation 252 was noted among all tissues, including those selected from pregnancies with evidence of SARS-CoV-2 253 fetal transmission. While the current study was not powered to identify true correlations with these 254 expression changes and fetal transmission, our findings do suggest that mechanisms in addition to altered 255

Di Mascio D. Maternal and Perinatal Outcomes of Pregnant Women with SARS-COV-2 333 infection. Ultrasound Obstet Gynecol. 2020. 334

Zeng H, Xu C, Fan J, et al. Antibodies in Infants Born to Mothers With COVID-19 Pneumonia. 335 Jama. 2020; 323:1848 -1849 

Kimberlin DW, Stagno S. Can SARS-CoV-2 Infection Be Acquired In Utero?: More Definitive 337

Evidence Is Needed. Jama. 2020. 338

Patanè Representative images of co-staining with cytokeratin 7 (green) and Rab5 (red). B. Representative 442 images of co-staining with cytokeratin 7 (green) and Rab7 (red). Scale bars: 12µm. Inset images: 443 secondary only negative control. Labels: sTB: syncytiotrophoblast cell, cTB: cytotrophoblast cell. 444 

COVID-19 Map

COVID-19 and newborn health: systematic review

Structural basis of receptor recognition by SARS-CoV-2

De novo phosphatidylcholine synthesis is required for 409 autophagosome membrane formation and maintenance during autophagy

5-Aminolevulinic acid tumor paint and photodynamic 412 therapy for myxofibrosarcoma: an in vitro study

TMPRSS2 and TMPRSS4 promote SARS-CoV-2 415 infection of human small intestinal enterocytes

Diverting intracellular trafficking of 417

Salmonella to the lysosome through activation of the late endocytic Rab7 by intracellular delivery 418 of muramyl dipeptide

IL-6 and IL-12 specifically regulate the expression of 420

Rab5 and Rab7 via distinct signaling pathways

CoV-2 infection: The role of cytokines in COVID-19 disease

Rab GTPase Function in Endosome and Lysosome 425